Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,46 MB, PDF-dokument

  • Wenxin Song
  • Anne P. Beigneux
  • Anne L. Grønnemose
  • Ye Yang
  • Yiping Tu
  • Priscilla Munguia
  • Jazmin Morales
  • Hyesoo Jung
  • Pieter J. De Jong
  • Cris J. Jung
  • Kazuya Miyashita
  • Takao Kimura
  • Katsuyuki Nakajima
  • Masami Murakami
  • Gabriel Birrane
  • Haibo Jiang
  • Peter Tontonoz
  • Loren G. Fong
  • Stephen G. Young

GPIHBP1, an endothelial cell (EC) protein, captures lipoprotein lipase (LPL) within the interstitial spaces (where it is secreted by myocytes and adipocytes) and transports it across ECs to its site of action in the capillary lumen. GPIHBP1's 3-fingered LU domain is required for LPL binding, but the function of its acidic domain (AD) has remained unclear. We created mutant mice lacking the AD and found severe hypertriglyceridemia. As expected, the mutant GPIHBP1 retained the capacity to bind LPL. Unexpectedly, however, most of the GPIHBP1 and LPL in the mutant mice was located on the abluminal surface of ECs (explaining the hypertriglyceridemia). The GPIHBP1-bound LPL was trapped on the abluminal surface of ECs by electrostatic interactions between the large basic patch on the surface of LPL and negatively charged heparan sulfate proteoglycans (HSPGs) on the surface of ECs. GPIHBP1 trafficking across ECs in the mutant mice was normalized by disrupting LPL-HSPG electrostatic interactions with either heparin or an AD peptide. Thus, GPIHBP1's AD plays a crucial function in plasma triglyceride metabolism; it sheathes LPL's basic patch on the abluminal surface of ECs, thereby preventing LPL-HSPG interactions and freeing GPIHBP1-LPL complexes to move across ECs to the capillary lumen.

OriginalsprogEngelsk
Artikelnummere157500
TidsskriftJournal of Clinical Investigation
Vol/bind132
Udgave nummer5
Antal sider15
ISSN0021-9738
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This work was supported by grants from the National Heart, Lung, and Blood Institute (HL087228, HL146358, and HL139725), a Fon-dation Leducq Transatlantic Network grant (19CVD04), NOVO Nordisk Foundation grant (NNF20OC0063444), and The John and Birthe Meyer Foundation. We are grateful to Gry Ellis Rasmussen for technical assistance and to Chris Allan, Junli Zhang, Leonel D. Joannas, and Patrick Heizer for working on early phases of this project.

Publisher Copyright:
© 2022 American Society for Clinical Investigation. All rights reserved.

ID: 300450482